Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
Invest New Drugs
; 35(1): 124, 2017 02.
Article
in En
| MEDLINE
| ID: mdl-27900530
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Invest New Drugs
Year:
2017
Document type:
Article
Affiliation country:
Brazil
Country of publication:
United States